KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Esperion Therapeutics (ESPR) over the last 7 years, with Q3 2025 value amounting to 0.85.

  • Esperion Therapeutics' Asset Utilization Ratio fell 363.31% to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year decrease of 363.31%. This contributed to the annual value of 1.21 for FY2024, which is 13582.19% up from last year.
  • As of Q3 2025, Esperion Therapeutics' Asset Utilization Ratio stood at 0.85, which was down 363.31% from 0.8 recorded in Q2 2025.
  • Over the past 5 years, Esperion Therapeutics' Asset Utilization Ratio peaked at 1.01 during Q4 2024, and registered a low of 0.21 during Q2 2022.
  • Its 5-year average for Asset Utilization Ratio is 0.53, with a median of 0.45 in 2023.
  • Within the past 5 years, the most significant YoY rise in Esperion Therapeutics' Asset Utilization Ratio was 294592.77% (2021), while the steepest drop was 7377.49% (2021).
  • Esperion Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.26 in 2021, then rose by 4.12% to 0.27 in 2022, then surged by 102.37% to 0.54 in 2023, then surged by 85.43% to 1.01 in 2024, then dropped by 15.42% to 0.85 in 2025.
  • Its Asset Utilization Ratio was 0.85 in Q3 2025, compared to 0.8 in Q2 2025 and 0.78 in Q1 2025.